Head, laboratory of Neuroscience
Tel Aviv University
danioffen@gmail.com

Dr. Offen earned his PhD in Molecular Biology at Weizmann Institute of Science and did his post-doctoral studies at the Albert Einstein College of Medicine in N.Y. Dr. Offen heads the Neurology Laboratory at Tel Aviv University and is an Associate Professor in the Department of Human Genetics and Biochemistry. Dr. Offen enjoys an internationally recognized reputation in neuroscience research. He has published over 150 original scientific papers on neurodegenerative diseases and is co-inventor in over a dozen patents, including those on which Brainstorm Cell Therapeutics’ pioneering technology is based. Dr. Offen is a co-founder of BrainStorm, a biotechnology company developing autologous stem cell therapies for ALS and currently conducting a Phase II clinical trial at Hadassah Medical Center in Jerusalem.